MTOR and ischemia: In the HFD 2-min TI group, mTOR, and p-mTOR immunoreactivity was further significantly increased (about 135%, p < 0.001, and 132%, p < 0.001 of the HFD sham group, respectively) at 2 days post-ischemia (Figure 8A-a5,B-b5,C,D).